
Bioorganic and Medicinal Chemistry Letters p. 307 - 310 (1996)
Update date:2022-08-05
Topics:
Rivero
Kevin
Kivlighn
Zingaro
Chang
Greenlee
Simple modifications made to our potent angiotensin II AT1 selective clinical candidate MK-996 provided a compound with balanced binding affinity to both the AT1 and the AT2 receptor subtype. This compound, L-162,389 is or
View Morewebsite:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
Shanghai Egoal Chemical Co.,Ltd
Contact:+86-21-50333091
Address:Yangming Garden Square 3,YangGao North Road 1188, Pudong New District, Shanghai
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
LIANYUNGANG YC FINE CHEMICAL CO., LTD
Contact:+86-518-858 99188
Address:Shangdong Modern Bldg, South Greenpark Road, Lianyungang, Jiangsu Pro. China
Doi:10.1016/j.tet.2016.01.021
(2016)Doi:10.1021/ol025627w
(2002)Doi:10.1016/S0040-4039(97)01728-0
(1997)Doi:10.1021/om400452q
(2013)Doi:10.1021/jo00058a005
(1993)Doi:10.1107/S010827019600491X
(1996)